NRP1 and prostate cancer: Similar results were obtained when Ag-TS was applied to PC-3 human prostate cancer cells pre-cultured in the presence of CdSe/ZnS-QDs coated with RPARPAR, a neuropilin-1-binding CendR peptide, with an N-terminal KCDG peptide linker (Fig. 4f)30.